Five-year and lifetime risk of breast cancer among U.S. subpopulations: Implications for magnetic resonance imaging screening

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2430-2436

  Graubard, Barry I ^a   Freedman, Andrew N ^a   Gail, Mitchell H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CAUCASIAN; ETHNICITY; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; UNITED STATES;

EID: 77958046845     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0324     Document Type: Article

References (32)

1. Saslow D, Boetes C, Burke W, et al, American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
2. Breast Cancer Risk Prediction Models NCI Website. Available from: http://riskfactor.cancer.gov/cancer-risk-prediction/breast.html.
3. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541-8. (Pubitemid 29457958)
4. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601. (Pubitemid 46621891)
5. Zakhireh J, Gomez R, Esserman L. Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer 2008;44:2742-52.
6. Elsamaloty H, Elzawawi MS, Mohammed S, Herial N. Increasing accuracy of detection of breast cancer with 3-T MRI. Am J Roentgenol 2009;192:1142-8.
7. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90: 1371-88.
8. Pleis JR, Schiller JS, Benson V, National Center for Health Statistics. Summary health statistics U.S. adults: National Health Interview Survey, 2000. Vital Health Stat 10 (215) 2003;10.
9. Pleis JR, Lethbridge-Ceiku M, National Center for Health Statistics. Summary health statistics U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10 (232) 2006;10.
10. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
11. National Health Interview Survey (NHIS). Available from: http://www. cdc.gov/nchs/nhis.htm.
12. Anderson SJ, Ahnn S, Duff K. NSABP breast cancer prevention trial risk assessment program, Version 2. NSABP Biostatistical Center technical report. Pittsburgh (PA): Department of Biostatistics, University of Pittsburgh; 1992.
13. Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007;99:1782-92.
14. Korn EL, Graubard BI. Analysis of health surveys. New York (NY): John Wiley & Sons; 1999, pp. 22-8, 64-8.
15. SAS Institute Inc. SAS/STAT 9.1 user's guide, version 9.1. Cary (NC): SAS Institute Inc; 2004.
16. Research Triangle Institute. SUDAAN language manual, release 9.0. Research Triangle Park (NC): Research Triangle Institute; 2004.
17. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66.
18. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86:620-5. (Pubitemid 24143172)
19. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600-7. (Pubitemid 24143169)
20. Bondy ML, Newman LA. Assessing breast cancer risk: evolution of the Gail model. Natl Cancer Inst 2006;98:1172-3.
21. Decarli A, Calza S, Masala G, Specchia C, Palli D, Gail MH. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European prospective investigation into cancer and nutrition cohort. J Natl Cancer Inst 2006;98:1686-93.
22. Parmigiani G, Chen S, Iversen ES, Jr., et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 2007; 147:441-50.
23. Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993;28:115-20. (Pubitemid 24056083)
24. Antoniou AC, Cunningham AP, Peto J, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008;98:1457-66.
25. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23: 1111-30.
26. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91.
27. Amir E, Evans DG, Shenton A, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003;40:807-14. (Pubitemid 37485490)
28. Gail MH, Mai PL. Comparing breast cancer risk assessment models. J Natl Cancer Inst 2010;102:665-8.
29. Euhus DM, Leitch AM, Huth JF, Peters GN. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J 2002;8:23-7.
30. McTiernan A, Kuniyuki A, Yasui Y, et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:333-8.
31. Murphy CD, Lee JM, Drohan B, et al. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer 2008;113:3116-20.
32. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.